Chris Hulls - Jun 17, 2024 Form 4 Insider Report for Life360, Inc. (LIF)

Role
Chief Executive Officer, Director
Signature
/s/ Jay Sood, Attorney-in-Fact
Stock symbol
LIF
Transactions as of
Jun 17, 2024
Transactions value $
-$3,300,615
Form type
4
Date filed
6/20/2024, 02:26 PM
Previous filing
Jun 11, 2024
Next filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIF Common Stock Sale -$3.08M -114K -5.87% $27.00* 1.83M Jun 17, 2024 Direct F1, F2, F3
transaction LIF Common stock Sale -$226K -8.36K -81.9% $27.00* 1.85K Jun 17, 2024 Held by ICCA Labs, LLC F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the full exercise by the underwriters of a greenshoe option of the previously reported underwritten secondary offering that closed on June 7, 2024.
F2 Includes 86,554 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F3 Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
F4 The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares sold and held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.